Robert Hugh Bradbury,David Buttar,Christopher De Savi,Craig Samuel Donald,Richard Albert Norman,Alfred Arthur Rabow,Gordon Stuart Currie,Heather Redfearn,Nadim Akhtar,Helen Elizabeth Williams,Matthew
申请号:
US15445000
公开号:
US20170326115A1
申请日:
2017.02.28
申请国别(地区):
US
年份:
2017
代理人:
摘要:
The invention concerns compounds of Formula (I)or pharmaceutically-acceptable salts thereof, wherein R1 to R5 have any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders.